ArticleMolecules (Basel, Switzerland)2022
Chemical Markers and Pharmacological Characters of
Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 45 citations in OpenAlex.
- Antibacterial activity of pelargonium graveolens essential oil nanoemulsion evaluated by microfluidics and DESI mass spectrometry.Scientific reports · 2026Article
- Article
- Multivariate Characterization of Essential Oils for Their Antibacterial Activity AgainstMolecules (Basel, Switzerland) · 2026Article
- Article
- GC/MS analysis and insecticidal activity of Pelargonium graveolens essential oil from Algeria against Culex pipiens and Culiseta longiareolata mosquito larvae.Die Naturwissenschaften · 2025Article
- Evaluation of in vitro-geranium (Pelargonium graveolens) plants affected by irradiation and chemical mutagens.BMC plant biology · 2025Article
- Geranium Oil Nanoemulsion Delivers More Potent and Persistent Fumigant Control ofFoods (Basel, Switzerland) · 2025Article
- Phytochemical profiling and network pharmacology-based prediction of Pelargonium graveolens essential oil in the context of Guillain-Barré syndrome.Scientific reports · 2025Article
- Review
- Inhibition of carbohydrate digestive enzymes by a complementary essential oil blend: in silico and mixture design approaches.Frontiers in pharmacology · 2025Article
- Antimicrobial and synergistic effects of lemongrass and geranium essential oils againstWorld journal of critical care medicine · 2024Article
- Phytochemical Investigations, Antioxidant and Insecticidal Properties of Essential Oil and Extracts from the Aerial Parts ofMolecules (Basel, Switzerland) · 2024Article
- Biological, phytochemical and molecular docking characteristics of Laurus nobilis L. fresh leaves essential oil from Palestine.BMC complementary medicine and therapies · 2024Article
- Natural Sources of Therapeutic Agents Used in Skin Conditions.Life (Basel, Switzerland) · 2024Review
- Exploring the Sustainable Exploitation of Bioactive Compounds inPlants (Basel, Switzerland) · 2023Review
- Comparative In Vitro and In Silico Enzyme Inhibitory Screening ofPlants (Basel, Switzerland) · 2023Article
- An integrated approach utilizing raman spectroscopy and chemometrics for authentication and detection of adulteration of agarwood essential oils.Frontiers in chemistry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.